FisherVista

FisherVista

@fishervista

28848 articles
Sales Nexus CRM

Articles

Pearl Makes National Home Performance Registry Free for Public Energy Programs

Pearl Makes National Home Performance Registry Free for Public Energy Programs

Pearl is offering its national home performance registry at no cost to state energy offices, municipalities, and utilities, enabling public energy programs to certify and record home upgrades permanently.
AMC Closes $200 Million Stock Offering to Repay Debt and Invest in Theater Upgrades

AMC Closes $200 Million Stock Offering to Repay Debt and Invest in Theater Upgrades

AMC Entertainment Holdings closed a $200 million registered direct offering of 95.25 million shares, using proceeds to redeem $125.47 million in senior notes and fund theater improvements, reducing debt and interest expenses.
MindWave Innovations Signals Shift from Bitcoin Ownership to Productive Capital

MindWave Innovations Signals Shift from Bitcoin Ownership to Productive Capital

MindWave Innovations Inc. is positioning Bitcoin as yield-generating capital through institutional-grade custody and treasury optimization, reflecting a broader industry transition from passive holding to active deployment.
Five Years After Surfside, NIST Report Confirms Building Showed Warning Signs Missed Without Continuous Monitoring

Five Years After Surfside, NIST Report Confirms Building Showed Warning Signs Missed Without Continuous Monitoring

NIST's final report on the Champlain Towers South collapse reveals weeks of visible structural failure before the disaster, highlighting how continuous AI-powered monitoring could have prevented the tragedy.
AMC Entertainment Closes $200 Million Offering, Plans to Retire Debt and Invest in Theater Upgrades

AMC Entertainment Closes $200 Million Offering, Plans to Retire Debt and Invest in Theater Upgrades

AMC Entertainment has closed a $200 million stock offering, intending to use proceeds to redeem $125.47 million in senior notes due 2027 and fund capital improvements, reducing future debt obligations and interest expenses.
BioAdaptives' MyndRenew(TM) Earns TruShield Certification, Completing WADA-Compliant Cognitive Health System

BioAdaptives' MyndRenew(TM) Earns TruShield Certification, Completing WADA-Compliant Cognitive Health System

BioAdaptives announces MyndRenew(TM) received TruShield Certified status, making MyndSystem(TM) fully compliant with WADA anti-doping standards, strengthening its position in sports nutrition and expanding market opportunities.
Why Calling Your Lender Before Missing a Payment Could Save Your Property

Why Calling Your Lender Before Missing a Payment Could Save Your Property

Borrowers who contact lenders before missing a payment secure better options like forbearance or modifications, while those who wait face legal costs and reduced leverage, according to Jack Miller of Gelt Financial LLC.
Onco-Innovations Featured in NetworkNewsAudio Editorial on DNA Repair Therapies

Onco-Innovations Featured in NetworkNewsAudio Editorial on DNA Repair Therapies

Onco-Innovations Limited, a Canadian oncology company, was highlighted in a NetworkNewsAudio editorial for its exclusive rights to PNKP inhibitor technology targeting DNA repair in cancer cells, positioning it in the growing DDR oncology market.
Quantum BioPharma Reaches Midpoint in MS Imaging Study, Early Results Show Promise

Quantum BioPharma Reaches Midpoint in MS Imaging Study, Early Results Show Promise

Quantum BioPharma announced that its collaborative imaging study with Massachusetts General Hospital for the multiple sclerosis drug candidate Lucid-MS has reached the halfway mark in patient enrollment, with preliminary analyses showing a robust signal in acute MS lesions and potential sensitivity to gray matter lesions.
User Feedback Highlights Vaso-Grow as a Leading Pump Support Formula

User Feedback Highlights Vaso-Grow as a Leading Pump Support Formula

Performance Supplements releases updated user feedback showing Vaso-Grow delivers sustained, intense pumps that experienced athletes describe as unmatched, distinguishing it in a crowded market through transparent labeling and clinically supported ingredients.
Nicola Mining’s First Drill Hole at Jotun Target Confirms Porphyry Copper System Potential

Nicola Mining’s First Drill Hole at Jotun Target Confirms Porphyry Copper System Potential

Nicola Mining announced that its initial drill hole at the Jotun target within the New Craigmont Copper Project in British Columbia intersected alteration and mineralization consistent with a prospective porphyry copper system, positioning Jotun as a priority target for further exploration.
LIXTE Biotechnology Joins Russell Microcap Index, Boosting Visibility Among Institutional Investors

LIXTE Biotechnology Joins Russell Microcap Index, Boosting Visibility Among Institutional Investors

LIXTE Biotechnology Holdings Inc. has been added to the Russell Microcap Index, a move expected to enhance its visibility with institutional investors and support its strategic shift toward AI energy infrastructure equipment and services.
Suntex Enterprises Advances Strategic Initiatives, Eyes OTCQB Uplisting

Suntex Enterprises Advances Strategic Initiatives, Eyes OTCQB Uplisting

Suntex Enterprises completes key milestones including audit engagement, board appointment, and construction project progress, positioning for OTCQB qualification.
Aseon Labs Raises $10 Million to Build Robotic Pit Stop Network for Autonomous Fleets

Aseon Labs Raises $10 Million to Build Robotic Pit Stop Network for Autonomous Fleets

Aseon Labs secured $10 million in seed funding to deploy decentralized robotic micro-depots that reduce downtime and empty miles for autonomous vehicles, addressing a critical operational bottleneck as fleets scale.
Quantum BioPharma Targets Multiple Sclerosis with Novel Myelin Repair Drug Candidate

Quantum BioPharma Targets Multiple Sclerosis with Novel Myelin Repair Drug Candidate

Quantum BioPharma's lead candidate Lucid-MS aims to address the massive unmet need in multiple sclerosis by targeting myelin degradation, with the global MS therapeutics market projected to reach $38.62 billion by 2030.
ETF Flows Suggest Capital Rotation from Bitcoin to XRP, But Picture Is More Nuanced

ETF Flows Suggest Capital Rotation from Bitcoin to XRP, But Picture Is More Nuanced

Recent ETF flow data indicates a potential shift of investment from Bitcoin to XRP, though the trend is less dramatic than it appears, with implications for crypto firms like Riot Blockchain.
Grid Upgrades Could Unlock 27 TWh of Renewable Energy in Europe, Aurora Report Finds

Grid Upgrades Could Unlock 27 TWh of Renewable Energy in Europe, Aurora Report Finds

A new Aurora Energy Research report reveals that strengthening European grid connections could unlock an additional 27 terawatt-hours of clean power, addressing the energy trilemma of emissions reduction, supply security, and cost management.
Anthropic Accuses Alibaba of Illegally Extracting AI Capabilities from Claude

Anthropic Accuses Alibaba of Illegally Extracting AI Capabilities from Claude

Anthropic has sent a letter to Congress alleging that Alibaba illicitly extracted AI capabilities from its flagship model Claude, escalating tensions in the US-China AI race.
Alphabet Shares Tumble as Firm Loses Key AI Staff

Alphabet Shares Tumble as Firm Loses Key AI Staff

Alphabet experienced its steepest market setback since 2025 after two key AI researchers resigned, intensifying investor concerns about the company's artificial intelligence strategy.
European Carmakers Pivot to Smaller EVs to Compete in Crowded Market

European Carmakers Pivot to Smaller EVs to Compete in Crowded Market

European automakers are shifting to smaller, affordable electric vehicles due to battery technology improvements and lower manufacturing costs, targeting city streets where larger models struggle.
US Health Care Spending Hits $5.7 Trillion in 2025, Driven by GLP-1 Drugs

US Health Care Spending Hits $5.7 Trillion in 2025, Driven by GLP-1 Drugs

New CMS data reveals U.S. health care spending surged to $5.7 trillion in 2025, the third consecutive year of over 7% growth, with expensive GLP-1 obesity drugs as a key driver.

Showing 3991-4011 of 28848 articles (Page 191 of 1374)